Wednesday, March 24, 2021

AstraZeneca COVID vaccine 76% effective in new US trial analysis

New analysis from vaccine developer uses latest data and follows rebuke from US health officials.
AstraZeneca COVID vaccine 76% effective in new US trial analysis
read more

No comments:

Post a Comment